Lupande, D., Kaishusha, D., Mihigo, C., Itongwa, M., Yenga, G. and Katchunga, P. (2017) GeneXpert MTB/RIF dans le dépistage de la tuberculose pulmonaire à l’Hôpital Provincial Général de Référence de Bukavu, à l’Est de la République Démocratique du Congo: Quelles leçons tirées après 10 mois d’utilisation? [Role of GeneXpert MTB/RIF Test in the Screening for Pulmonary Tuberculosis at the General Referral Provincial Hospital of Bukavu, in the East of the Democratic Republic of the Congo: Balance after 10 Months of Use]. The Pan African Medical Journal, 27, Article 260.
https://doi.org/10.11604/pamj.2017.27.260.12575

has been cited by the following article:

• TITLE: Unveiling the Threat: Case Reports of Extra-Pulmonary Tuberculosis among Sanctuary Chimpanzees

  AUTHORS: Emeline Chanove, Yedra Feltrer, Antoine Collomb-Clerc, Angela Ceballos-Caro, Marina Spinu

  KEYWORDS: Extrapulmonary Tuberculosis, Tuberculosis, Chimpanzees, Zoonotic Risk, Biosecurity, Diagnosis Challenges

  JOURNAL NAME: Advances in Infectious Diseases, Vol.14 No.1, January 31, 2024

  ABSTRACT: Primate sanctuaries across Africa play a pivotal role in the rescue and rehabilitation of confiscated and rescued wild primates, many of whom have had extensive contact with humans prior to their arrival and throughout the rehabilitation process, heightening the risk of disease transmission. While tuberculosis is not naturally occurring in free-living chimpanzees, it has been extensively observed in captive primates that have been in close proximity to humans or other captive primates infected with Mycobacterium tuberculosis. This case report delves into an outbreak of extra-pulmonary tuberculosis among juvenile chimpanzees within a sanctuary, detailing the associated diagnostic challenges and treatment approaches. The five cases had close contact with a caregiver infected with tuberculosis, subsequently transmitting the infection to other in-contact chimpanzees. Prolonged treatment, employing the human protocol of quadri-therapy (rifampicin, isoniazid, pyrazinamide, and ethambutol), followed by bi-therapy (rifampicin and isoniazid), resulted in complete resolution for all five cases. These cases underscore the critical importance of maintaining high levels of biosecurity, implementing effective quarantine measures, and adhering to strict hygiene practices when working with non-human primates.